3SBio gets 'going private' proposal from board
China | News | By BioSpectrum Bureau | 0 Comment | 13 Sep, 2012
Singapore: 3SBio received a preliminary non-binding proposal letter dated September 12, 2012, from its chairman and CEO...Read more
Mr Reilly to be deported back to UK from China
China | News | By BioSpectrum Bureau | 0 Comment | 22 Sep, 2014
Singapore: Mr Mark Reilly, the former head of British drug maker GlaxoSmithKline, who has been at the center of the brib...Read more
Mc Donalds' and KFC may be using rotten meat
China | News | By BioSpectrum Bureau | 0 Comment | 31 Jul, 2014
Singapore: A shocking revelation, by the quality control manager at Husi Food, China indicated that expired meat was reu...Read more
Chinese medicine firm eyes Indian antibiotic market
China | News | By BioSpectrum Bureau | 0 Comment | 15 Jul, 2013
‎Singapore: Tianyin Pharmaceutical (TPI), China-based pharmaceutical company that specializes in patented biopharm...Read more
China firm develops new therapeutic vaccine for rabies
China | News | By BioSpectrum Bureau | 0 Comment | 17 Mar, 2015
Singapore: China's Yisheng Biopharma, a biopharmaceutical company developing vaccines, has developed a new vaccine for t...Read more
WuXi, PRA collaborate to provide services in China
China | News | By BioSpectrum Bureau | 0 Comment | 19 Dec, 2012
‎Singapore: WuXi PharmaTech, a leading contract research organization with operations in China US, and PRA have si...Read more
Biotechnology, medicine is Taiwan's next star industry
China | Analysis | By BioSpectrum Bureau | 0 Comment | 04 Sep, 2013
Singapore: Taiwan is striving to elevate its biotechnology and medicine industry with a combined support from both the p...Read more
China journeys from imitation to innovation
China | Analysis | By BioSpectrum Bureau | 2 Comment | 23 May, 2012
With a population of over 1.3 billion, China is poised for continued growth in the life sciences sector. There are sever...Read more
Gilead's Viread patent revoked in China
China | News | By BioSpectrum Bureau | 0 Comment | 08 Aug, 2013
Singapore: China's State Intellectual Property Office (SIPO) has yanked the patent for Gilead Sciences popular HIV and h...Read more
Lilly, Fidelity fund Innovent to develop cancer antibody
China | News | By BioSpectrum Bureau | 0 Comment | 22 Nov, 2012
Singapore: Innovent Biologics, a company dedicated to the development and manufacturing of monoclonal antibodies, is con...Read more
Heartbeat grows 350% year-over-year
China | News | By BioSpectrum Bureau | 0 Comment | 31 May, 2013
Singapore: Heartbeat Experts, the global leader in stakeholder management solutions for the life sciences industry has a...Read more
Gene expression for personalized medicine: Report
China | Analysis | By BioSpectrum Bureau | 2 Comment | 10 Jun, 2014
Singapore: Gene expression profiling can bring significant improvements to disease profiling and diagnoses based on gene...Read more
H7N9 China bird flu update: 38 infected, 10 dead
China | News | By BioSpectrum Bureau | 0 Comment | 12 Apr, 2013
Singapore: The National Health and Family Planning Commission of China has notified WHO of an additional 10 laboratory-...Read more
Jeffery Bacha: DelMar targets orphan cancer drugs
China | Influencers | By BioSpectrum Bureau | 0 Comment | 07 Nov, 2012
DelMar Pharmaceuticals was founded in 2010 to rapidly develop and commercialize proven cancer therapies in new indicatio...Read more
HUYA partners with Shanghai Zhangjiang Biotech
China | News | By BioSpectrum Bureau | 0 Comment | 07 Mar, 2013
Singapore: HUYA Bioscience International has entered into a collaborative partnership with Shanghai Zhangjiang Biotech a...Read more
BGI Shenzhen uses NGS to find mutation in IVF embryo
China | News | By BioSpectrum Bureau | 0 Comment | 23 Jul, 2013
Singapore: China's BGI Shenzhen along with Reproductive and Genetic Hospital Citic-Xiangya has successfully applied Next...Read more
BIO China kicks-off in Beijing
China | News | By BioSpectrum Bureau | 0 Comment | 12 Nov, 2013
Singapore: Executives from biotech and pharmaceutical companies, along with investment firms from North America, Europe ...Read more
APAC Epilepsy Therapeutics market to touch $1.5 bn by 2019
China | Analysis | By BioSpectrum Bureau | 2 Comment | 28 Feb, 2014
Singapore: The epilepsy therapeutics market value in the Asia-Pacific (APAC) region, Australia, China, India and Japan, ...Read more